Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
$343.49
+2.4%
$317.62
$287.20
$512.76
$7.93B0.9326,594 shs264,314 shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$537.73
0.0%
$478.10
$306.70
$628.92
$15.36B1.15300,837 shs231,155 shs
MSCI Inc stock logo
MSCI
MSCI
$628.83
-1.3%
$596.88
$501.08
$644.77
$45.77B1.24642,525 shs680,882 shs
Zoetis Inc. stock logo
ZTS
Zoetis
$76.44
-0.6%
$77.33
$71.47
$160.48
$32.10B0.755.80 million shs7.54 million shs
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
0.00%+0.75%+11.45%-4.76%-29.22%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
0.00%-0.09%+16.85%+3.29%+70.80%
MSCI Inc stock logo
MSCI
MSCI
0.00%+4.21%+8.10%+10.72%+9.88%
Zoetis Inc. stock logo
ZTS
Zoetis
0.00%+1.27%-2.85%-37.54%-49.53%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
$343.49
+2.4%
$317.62
$287.20
$512.76
$7.93B0.9326,594 shs264,314 shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$537.73
0.0%
$478.10
$306.70
$628.92
$15.36B1.15300,837 shs231,155 shs
MSCI Inc stock logo
MSCI
MSCI
$628.83
-1.3%
$596.88
$501.08
$644.77
$45.77B1.24642,525 shs680,882 shs
Zoetis Inc. stock logo
ZTS
Zoetis
$76.44
-0.6%
$77.33
$71.47
$160.48
$32.10B0.755.80 million shs7.54 million shs
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
0.00%+0.75%+11.45%-4.76%-29.22%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
0.00%-0.09%+16.85%+3.29%+70.80%
MSCI Inc stock logo
MSCI
MSCI
0.00%+4.21%+8.10%+10.72%+9.88%
Zoetis Inc. stock logo
ZTS
Zoetis
0.00%+1.27%-2.85%-37.54%-49.53%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
1.82
Reduce$375.809.41% Upside
Medpace Holdings, Inc. stock logo
MEDP
Medpace
2.07
Hold$469.50-12.69% Downside
MSCI Inc stock logo
MSCI
MSCI
3.08
Buy$713.5013.46% Upside
Zoetis Inc. stock logo
ZTS
Zoetis
2.41
Hold$120.8358.07% Upside

Current Analyst Ratings Breakdown

Latest ZTS, KNSL, MEDP, and MSCI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/17/2026
MSCI Inc stock logo
MSCI
MSCI
Initiated CoverageBuy$760.00
7/16/2026
MSCI Inc stock logo
MSCI
MSCI
UpgradeBuy (B-)Buy (B)
7/13/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Boost Price TargetOutperform$495.00 ➝ $586.00
7/10/2026
MSCI Inc stock logo
MSCI
MSCI
Boost Price TargetOverweight$700.00 ➝ $735.00
7/10/2026
MSCI Inc stock logo
MSCI
MSCI
Boost Price TargetBuy$715.00 ➝ $730.00
7/9/2026
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
Boost Price TargetEqual Weight$357.00 ➝ $366.00
7/8/2026
MSCI Inc stock logo
MSCI
MSCI
Boost Price TargetStrong-Buy$730.00 ➝ $760.00
7/8/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Reiterated RatingOutperformNeutral$477.00 ➝ $547.00
7/8/2026
MSCI Inc stock logo
MSCI
MSCI
Boost Price TargetStrong-Buy$730.00 ➝ $760.00
7/7/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
DowngradeBuyHold$490.00 ➝ $515.00
7/6/2026
Zoetis Inc. stock logo
ZTS
Zoetis
Lower Price TargetBuy$140.00 ➝ $95.00
(Data available from 7/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
$1.87B4.23$19.82 per share17.33$84.66 per share4.06
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$2.53B6.07$17.01 per share31.61$16.30 per share32.99
MSCI Inc stock logo
MSCI
MSCI
$3.24B14.13$21.09 per share29.82($36.13) per share-17.40
Zoetis Inc. stock logo
ZTS
Zoetis
$9.53B3.36$7.55 per share10.12$7.56 per share10.11
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
$503.61M$22.7215.1215.781.1127.48%25.82%8.20%7/23/2026 (Estimated)
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$451.12M$15.9133.8028.972.6917.19%120.89%24.79%7/22/2026 (Confirmed)
MSCI Inc stock logo
MSCI
MSCI
$1.20B$17.5135.9127.622.2740.74%-65.48%24.49%7/21/2026 (Estimated)
Zoetis Inc. stock logo
ZTS
Zoetis
$2.67B$6.0312.6810.401.1927.80%66.85%18.79%8/6/2026 (Estimated)

Latest ZTS, KNSL, MEDP, and MSCI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
Zoetis Inc. stock logo
ZTS
Zoetis
$1.85N/AN/AN/A$2.50 billionN/A
7/23/2026Q2 2026
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
$5.09N/AN/AN/A$445.14 millionN/A
7/22/2026Q2 2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.98N/AN/AN/A$689.53 millionN/A
7/21/2026Q2 2026
MSCI Inc stock logo
MSCI
MSCI
$4.97N/AN/AN/A$869.54 millionN/A
5/7/2026Q1 2026
Zoetis Inc. stock logo
ZTS
Zoetis
$1.60$1.53-$0.07$1.42$2.30 billion$2.26 billion
4/23/2026Q1 2026
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
$4.70$5.11+$0.41$4.88$410.25 million$466.71 million
4/22/2026Q1 2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.74$4.28+$0.54$4.28$697.82 million$706.60 million
4/21/2026Q1 2026
MSCI Inc stock logo
MSCI
MSCI
$4.38$4.55+$0.17$5.53$830.91 million$850.80 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
$1.000.29%+13.56%4.40%2 Years
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/AN/AN/AN/AN/A
MSCI Inc stock logo
MSCI
MSCI
$8.201.30%+19.78%46.83%11 Years
Zoetis Inc. stock logo
ZTS
Zoetis
$2.122.77%+20.11%35.16%14 Years

Latest ZTS, KNSL, MEDP, and MSCI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/20/2026
Zoetis Inc. stock logo
ZTS
Zoetis
quarterly$0.532.66%7/20/20267/20/20269/1/2026
5/11/2026
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
quarterly$0.250.32%5/28/20265/28/20266/11/2026
4/20/2026
MSCI Inc stock logo
MSCI
MSCI
quarterly$2.051.46%5/15/20265/15/20265/29/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
0.11
0.10
0.10
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/A
0.85
0.85
MSCI Inc stock logo
MSCI
MSCI
N/A
0.86
0.86
Zoetis Inc. stock logo
ZTS
Zoetis
2.80
3.15
1.91

Institutional Ownership

CompanyInstitutional Ownership
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
85.36%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
77.98%
MSCI Inc stock logo
MSCI
MSCI
89.97%
Zoetis Inc. stock logo
ZTS
Zoetis
92.80%

Insider Ownership

CompanyInsider Ownership
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
5.60%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
20.50%
MSCI Inc stock logo
MSCI
MSCI
3.76%
Zoetis Inc. stock logo
ZTS
Zoetis
0.22%
CompanyEmployeesShares OutstandingFree FloatOptionable
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
47023.06 million21.77 millionOptionable
Medpace Holdings, Inc. stock logo
MEDP
Medpace
6,20028.56 million22.71 millionOptionable
MSCI Inc stock logo
MSCI
MSCI
6,26872.80 million70.06 millionOptionable
Zoetis Inc. stock logo
ZTS
Zoetis
14,500419.23 million418.31 millionOptionable

Recent News About These Companies

Why Did Zoetis (NYSE:ZTS) Launch Spark S&P 500 Interest?
Zoetis: An Attractive Risk-Reward Opportunity
Zoetis (NYSE:ZTS) Stock Acquired Rep. Byron Donalds

New MarketBeat Followers Over Time

Media Sentiment Over Time

Kinsale Capital Group stock logo

Kinsale Capital Group NYSE:KNSL

$343.48 +7.97 (+2.37%)
Closing price 07/17/2026 03:59 PM Eastern
Extended Trading
$344.61 +1.12 (+0.33%)
As of 07/17/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Kinsale Capital Group, Inc., a specialty insurance company, engages in the provision of property and casualty insurance products in the United States. The company's commercial lines offerings include commercial property, small business casualty and property, excess and general casualty, construction, allied health, life sciences, entertainment, energy, environmental, excess professional, health care, public entity, commercial auto, inland marine, aviation, ocean marine, product recall, and railroad, as well as product, professional, and management liability insurance. It markets and sells its insurance products in all 50 states, the District of Columbia, the Commonwealth of Puerto Rico, and the U.S. Virgin Islands primarily through a network of independent insurance brokers. The company was founded in 2009 and is headquartered in Richmond, Virginia.

Medpace stock logo

Medpace NASDAQ:MEDP

$537.73 -0.19 (-0.04%)
Closing price 07/17/2026 04:00 PM Eastern
Extended Trading
$534.30 -3.43 (-0.64%)
As of 07/17/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

MSCI stock logo

MSCI NYSE:MSCI

$628.83 -8.41 (-1.32%)
Closing price 07/17/2026 03:59 PM Eastern
Extended Trading
$628.83 -0.01 (0.00%)
As of 07/17/2026 06:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MSCI Inc., together with its subsidiaries, provides critical decision support tools and solutions for the investment community to manage investment processes worldwide. The Index segment provides indexes for use in various areas of the investment process, including indexed financial product, such as ETFs, mutual funds, annuities, futures, options, structured products, and over-the-counter derivatives; performance benchmarking; portfolio construction and rebalancing; and asset allocation, as well as licenses GICS and GICS Direct. The Analytics segment offers risk management, performance attribution and portfolio management content, application, an integrated view of risk and return service, and an analysis of market, credit, liquidity, counterparty, and climate risk across asset classes; managed services, including consolidation of client portfolio data, review and reconciliation of input data and results, and customized reporting; and HedgePlatform to measure, evaluate, and monitor the risk of hedge fund investments. The ESG and Climate segment provides products and services that help institutional investors understand how ESG impacts the long-term risk and return of their portfolio and individual security-level investments; and data, ratings, research, and tools to help investors navigate increasing regulation. The All Other Private Assets segment includes real estate and infrastructure data, benchmarks, return-analytics, climate assessments and market insights; business intelligence to real estate owners, managers, developers, and brokers; and offers investment decision support tools for private capital. The Private Capital Solutions segment offers tools to help private asset investors across mission-critical workflows, such as sourcing terms and conditions, evaluating operating performance, managing risk and other activities supporting private capital investing. MSCI Inc. was incorporated in 1998 and is headquartered in New York, New York.

Zoetis stock logo

Zoetis NYSE:ZTS

$76.44 -0.47 (-0.61%)
Closing price 07/17/2026 03:59 PM Eastern
Extended Trading
$76.30 -0.15 (-0.19%)
As of 07/17/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.